We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+23.34%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$509M
AUM Growth
+$16.9M
(+3.4%)
Cap. Flow
-$34.9M
Cap. Flow
% of AUM
-6.86%
Top 10 Holdings %
Top 10 Hldgs %
30.28%
Holding
101
New
29
Increased
19
Reduced
23
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CarMax
KMX
|
+$11.7M |
| 2 |
Walt Disney
DIS
|
+$8.09M |
| 3 |
Beyond Meat
BYND
|
+$7.92M |
| 4 |
HEICO Corp Class A
HEI.A
|
+$7.1M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madison Square Garden
MSGS
|
+$6.89M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$6.12M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$4.78M |
| 4 |
Boeing
BA
|
+$4.58M |
| 5 |
Ashland
ASH
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.67% |
| 2 | Technology | 20.5% |
| 3 | Communication Services | 11.6% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Materials | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $21.5M | 4.22% |
245,000
+145,000
| +145% | +$12.4M |
|
2
PUT
Invesco QQQ Trust
QQQ
$455B
| $20.5M | 4.03% |
110,000
-152,000
| -58% | -$28M |
|
3
Okta
OKTA
$24.1B
| $18.5M | 3.64% |
150,000
+3,000
| +2% | +$326K |
|
|
EXAS
4
DELISTED
Exact Sciences
EXAS
| $16M | 3.14% |
135,300
-22,700
| -14% | -$2.29M |
|
5
Sarepta Therapeutics
SRPT
$1.66B
| $14M | 2.75% |
92,000
+2,000
| +2% | +$243K |
|
|
ARNA
6
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $13.5M | 2.65% |
230,000
+35,000
| +18% | +$1.81M |
|
|
7
CarMax
KMX
$8.27B
| $13M | 2.56% |
+150,000
| New | +$11.7M |
|
8
Netflix
NFLX
$292B
| $12.7M | 2.49% |
345,000
+25,000
| +8% | +$902K |
|
9
Amazon
AMZN
$2.5T
| $12.5M | 2.45% |
132,000
+26,100
| +25% | +$2.43M |
|
10
Roku
ROKU
$21.1B
| $12M | 2.35% |
132,000
+15,000
| +13% | +$1.2M |
|
|
11
Beyond Meat
BYND
$288M
| $11.4M | 2.24% |
+71,000
| New | +$7.92M |
|
12
Atlanta Braves Holdings Series B
BATRK
$3.23B
| $11M | 2.17% |
395,000
+15,000
| +4% | +$412K |
|
13
Inspire Medical Systems
INSP
$1.42B
| $10M | 1.97% |
165,000
+26,000
| +19% | +$1.4M |
|
14
Atlassian
TEAM
$22B
| $9.42M | 1.85% |
72,000
+3,000
| +4% | +$361K |
|
|
GWPH
15
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $9.31M | 1.83% |
54,000
-2,500
| -4% | -$432K |
|
16
Martin Marietta Materials
MLM
$33.6B
| $9.21M | 1.81% |
40,000
+14,000
| +54% | +$3.03M |
|
|
GRA
17
DELISTED
W.R. Grace & Co.
GRA
| $8.98M | 1.76% |
118,000
+4,000
| +4% | +$299K |
|
18
Zai Lab
ZLAB
$2.17B
| $8.54M | 1.68% |
245,000
+70,000
| +40% | +$2.06M |
|
|
19
Walt Disney
DIS
$165B
| $8.52M | 1.67% |
+61,000
| New | +$8.09M |
|
|
COUP
20
DELISTED
Coupa Software Incorporated
COUP
| $8.1M | 1.59% |
64,000
| – | – |
|
21
eHealth
EHTH
$42.5M
| $8.09M | 1.59% |
94,000
+1,000
| +1% | +$67.3K |
|
22
RingCentral
RNG
$4.05B
| $8.04M | 1.58% |
70,000
-4,500
| -6% | -$519K |
|
|
23
HEICO Corp Class A
HEI.A
$35.4B
| $7.96M | 1.56% |
+77,000
| New | +$7.1M |
|
24
DexCom
DXCM
$27.6B
| $7.79M | 1.53% |
208,000
-112,000
| -35% | -$3.52M |
|
25
PUT
iShares Russell 2000 ETF
IWM
$80.9B
| $7.77M | 1.53% |
50,000
-75,000
| -60% | -$11.6M |
|
Similar funds
AGA
ATS
RIM
ACM
CAM
LSA
GWA
Atika Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Atika Capital Management held 101 positions worth $509M, up 3.4% from $492M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Atika Capital Management withdrew a net $34.9M in Q2 2019, closing 24 positions and reducing 23 holdings. Its most notable exit was Madison Square Garden, an estimated $6.89M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Atika Capital Management opened a new position in CarMax worth $13M.
- Atika Capital Management's largest Q2 2019 buy was CarMax: 150,000 shares worth $13M.
- Atika Capital Management added most to Martin Marietta Materials in Q2 2019, an estimated $3.03M increase.
- Atika Capital Management's biggest Q2 2019 reduction was Ashland, cutting an estimated $4.56M.
- Atika Capital Management fully exited Madison Square Garden in Q2 2019, selling an estimated $6.89M.
- Atika Capital Management's ten largest holdings make up 30% of its $509M portfolio in Q2 2019.
- Atika Capital Management opened 29 new positions and closed 24 in Q2 2019.
- Atika Capital Management's portfolio value rose 3.4% quarter-over-quarter to $509M.
Based on Atika Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.